Tonix Pharmaceuticals Holding Corp. (TNXP) Insider Trading Disclosures
Tonix Pharmaceuticals Holding Corp. (TNXP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TNXP
CIK: 1430306
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerBlair Robbins
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001493152-26-047139 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-10-01 | 8-K | 0001493152-26-045603 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | 8-K | 0001493152-26-043644 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001493152-26-041689 | View SEC Doc Filr Page |
| 3 | 2026-09-08 | 2026-09-04 | 3 | 0001493152-26-041688 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | 4 | 0001493152-26-040736 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001999371-26-018494 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-18 | 8-K | 0001493152-26-039000 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005208 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001167557-26-000168 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | QUARTERLY REPORT | 0001999371-26-017452 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001493152-26-036740 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001493152-26-035741 | View SEC Doc Filr Page |
| 8-K | 2026-07-21 | 2026-07-20 | 8-K | 0001493152-26-034079 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-13 | 8-K | 0001493152-26-032925 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-06-30 | 4 | 0001493152-26-032615 | View SEC Doc Filr Page |
| S-8 | 2026-07-01 | — | S-8 | 0001493152-26-031574 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-29 | 8-K | 0001493152-26-030408 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-15 | — | SCHEDULE 13G Filing | 0001104659-26-074154 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-12 | 4 | 0001493152-26-028608 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-08 | 4 | 0001493152-26-027985 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-09 | 4 | 0001493152-26-027986 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-08 | 8-K | 0001493152-26-027621 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-27 | 8-K | 0001493152-26-025324 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-003484 | View SEC Doc Filr Page |